A validated integrated clinical and molecular glioblastoma long-term survival-predictive nomogram

BACKGROUND: Glioblastoma (GBM) is the most common primary malignant brain tumor in adulthood. Despite multimodality treatments, including maximal safe resection followed by irradiation and chemotherapy, the median overall survival times range from 14 to 16 months. However, a small subset of GBM pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferguson, Sherise D, Hodges, Tiffany R, Majd, Nazanin K, Alfaro-Munoz, Kristin, Al-Holou, Wajd N, Suki, Dima, de Groot, John F, Fuller, Gregory N, Xue, Lee, Li, Miao, Jacobs, Carmen, Rao, Ganesh, Colen, Rivka R, Xiu, Joanne, Verhaak, Roel, Spetzler, David, Khasraw, Mustafa, Sawaya, Raymond, Long, James P, Heimberger, Amy B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Clinical Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780842/
https://www.ncbi.nlm.nih.gov/pubmed/33426529
http://dx.doi.org/10.1093/noajnl/vdaa146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780842/
https://www.ncbi.nlm.nih.gov/pubmed/33426529
http://dx.doi.org/10.1093/noajnl/vdaa146

Ejemplares similares